Search research articles
Contact Us
Filters
Showing results (31-40 of 56) with videos related to
Page
of 6
Sort By:
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
April 27, 2000
Expression of retinoic acid receptors in non-neoplastic epithelial disorders of the vulva and normal vulvar skin
J Berger, A Telser, M Widschwendter, et al.
Placenta
|
December 7, 2010
Hypomethylation along with increased H19 expression in placentas from pregnancies complicated with fetal growth restriction
O Koukoura, S Sifakis, A Zaravinos, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
June 3, 2015
Time to diagnosis of Type I or II invasive epithelial ovarian cancers: a multicentre observational study using patient questionnaire and primary care records
Aww Lim, D Mesher, A Gentry-Maharaj, et al.
British Journal of Cancer
|
January 1, 1997
High serum levels of soluble CD44 variant isoform v5 are associated with favourable clinical outcome in ovarian cancer
A G Zeimet, M Widschwendter, M Uhl-Steidl, et al.
Gynakologisch-Geburtshilfliche Rundschau
|
January 1, 1996
[Immunostimulating protein 90K in ovarian carcinoma]
A G Zeimet, C Marth, D Fuchs, et al.
British Journal of Cancer
|
January 1, 1997
Cisplatin resistance is associated with reduced interferon-gamma-sensitivity and increased HER-2 expression in cultured ovarian carcinoma cells
C Marth, M Widschwendter, J Kaern, et al.
International Journal of Cancer
|
May 2, 1997
Activity of retinoic acid receptor-gamma selectively binding retinoids alone and in combination with interferon-gamma in breast cancer cell lines
M Widschwendter, G Daxenbichler, Z Culig, et al.
Cancer Research
|
October 23, 1997
Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer
M Widschwendter, J Berger, G Daxenbichler, et al.
British Journal of Cancer
|
November 13, 2003
MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status
H M Müller, H Fiegl, G Goebel, et al.
International Journal of Cancer
|
December 15, 1994
Effects of type-I and -II interferons on 90K antigen expression in ovarian carcinoma cells
C Marth, A Dreps, C Natoli, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 56) with videos related to
Sort By:
Page
of 6
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
April 27, 2000
Expression of retinoic acid receptors in non-neoplastic epithelial disorders of the vulva and normal vulvar skin
J Berger, A Telser, M Widschwendter, et al.
Placenta
|
December 7, 2010
Hypomethylation along with increased H19 expression in placentas from pregnancies complicated with fetal growth restriction
O Koukoura, S Sifakis, A Zaravinos, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
June 3, 2015
Time to diagnosis of Type I or II invasive epithelial ovarian cancers: a multicentre observational study using patient questionnaire and primary care records
Aww Lim, D Mesher, A Gentry-Maharaj, et al.
British Journal of Cancer
|
January 1, 1997
High serum levels of soluble CD44 variant isoform v5 are associated with favourable clinical outcome in ovarian cancer
A G Zeimet, M Widschwendter, M Uhl-Steidl, et al.
Gynakologisch-Geburtshilfliche Rundschau
|
January 1, 1996
[Immunostimulating protein 90K in ovarian carcinoma]
A G Zeimet, C Marth, D Fuchs, et al.
British Journal of Cancer
|
January 1, 1997
Cisplatin resistance is associated with reduced interferon-gamma-sensitivity and increased HER-2 expression in cultured ovarian carcinoma cells
C Marth, M Widschwendter, J Kaern, et al.
International Journal of Cancer
|
May 2, 1997
Activity of retinoic acid receptor-gamma selectively binding retinoids alone and in combination with interferon-gamma in breast cancer cell lines
M Widschwendter, G Daxenbichler, Z Culig, et al.
Cancer Research
|
October 23, 1997
Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer
M Widschwendter, J Berger, G Daxenbichler, et al.
British Journal of Cancer
|
November 13, 2003
MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status
H M Müller, H Fiegl, G Goebel, et al.
International Journal of Cancer
|
December 15, 1994
Effects of type-I and -II interferons on 90K antigen expression in ovarian carcinoma cells
C Marth, A Dreps, C Natoli, et al.
Page
of 6